Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 4,366 | 31 | 40 | 44 | 44 |
| Gross Profit | 4,366 | 31 | 40 | 44 | 44 |
| Operating Expenses | 19,267 | 21,826 | 19,381 | 21,309 | 19,385 |
| Operating Income | -14,902 | -21,795 | -19,342 | -21,265 | -19,341 |
| Other Income | 2,816 | -425 | -79 | 449 | 77 |
| Pre-tax Income | -12,086 | -22,220 | -19,421 | -20,816 | -19,264 |
| Net Income Continuous | -12,086 | -22,217 | -19,421 | -20,816 | -19,264 |
| Net Income | $-12,086 | $-22,222 | $-19,421 | $-20,816 | $-19,264 |
| EPS Basic Total Ops | -0.17 | -0.35 | -0.32 | -0.35 | -0.32 |
| EPS Basic Continuous Ops | -0.17 | -0.34 | -0.32 | -0.35 | -0.32 |
| EPS Diluted Total Ops | -0.17 | -0.35 | -0.32 | -0.35 | -0.32 |
| EPS Diluted Continuous Ops | -0.17 | -0.34 | -0.32 | -0.35 | -0.32 |
| EBITDA(a) | $-13,716 | $-20,921 | $-18,501 | $-20,390 | $-18,439 |